BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2219196)

  • 1. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture.
    Niwa T; Bradlow HL; Fishman J; Swaneck GE
    Steroids; 1990 Jul; 55(7):297-302. PubMed ID: 2219196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of estradiol 2- and 16-alpha-hydroxylase activities in MCF-7 human breast cancer cells in culture using radiometric analysis.
    Niwa T; Bradlow HL; Fishman J; Swaneck GE
    J Steroid Biochem; 1989 Aug; 33(2):311-4. PubMed ID: 2770303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of estradiol by human breast cancer.
    Abul-Hajj YJ; Thijssen JH; Blankenstein MA
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1171-8. PubMed ID: 3416901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological effect of estrogen metabolites in human breast cancer].
    Imoto S
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):505-17. PubMed ID: 1614394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
    Merchant M; Krishnan V; Safe S
    Toxicol Appl Pharmacol; 1993 Jun; 120(2):179-85. PubMed ID: 8390116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
    Angus WG; Larsen MC; Jefcoate CR
    Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?
    Nebert DW
    J Natl Cancer Inst; 1993 Dec; 85(23):1888-91. PubMed ID: 8230275
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
    Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
    Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
    Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
    Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the induction of DNA strand breaks and poly(ADP-ribose) polymerase-1 activation by 17beta-estradiol in human breast carcinoma cells through alteration of CYP1A1 and CYP1B1 expression.
    Lin PH; Lin CH; Huang CC; Fang JP; Chuang MC
    Chem Res Toxicol; 2008 Jul; 21(7):1337-47. PubMed ID: 18558727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of estrogen metabolism on proliferation of human breast cancer.
    Imoto S; Mitani F; Enomoto K; Fujiwara K; Ikeda T; Kitajima M; Ishimura Y
    Breast Cancer Res Treat; 1997 Jan; 42(1):57-64. PubMed ID: 9116318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.
    Osborne MP; Bradlow HL; Wong GY; Telang NT
    J Natl Cancer Inst; 1993 Dec; 85(23):1917-20. PubMed ID: 8230281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CYP1A1 and CYP1B1 in T-47D human breast cancer cells by benzo[a]pyrene is diminished by arsenite.
    Spink DC; Katz BH; Hussain MM; Spink BC; Wu SJ; Liu N; Pause R; Kaminsky LS
    Drug Metab Dispos; 2002 Mar; 30(3):262-9. PubMed ID: 11854143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of hepatic CYP2A1, CYP2C11, and CYP3A9 expression in adult rats by neonatal administration of tamoxifen.
    Kawai M; Bandiera SM; Chang TK; Poulet FM; Vancutsem PM; Bellward GD
    Drug Metab Dispos; 1999 Dec; 27(12):1392-8. PubMed ID: 10570019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens.
    Weisz J; Bui QD; Roy D; Liehr JG
    Endocrinology; 1992 Aug; 131(2):655-61. PubMed ID: 1386303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor.
    Harris M; Piskorska-Pliszczynska J; Zacharewski T; Romkes M; Safe S
    Cancer Res; 1989 Aug; 49(16):4531-5. PubMed ID: 2545344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer.
    Fishman J; Schneider J; Hershcope RJ; Bradlow HL
    J Steroid Biochem; 1984 Apr; 20(4B):1077-81. PubMed ID: 6727352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells.
    Sica G; Iacopino F; Robustelli della Cuna G; Marchetti P; Marini L
    J Cancer Res Clin Oncol; 1994; 120(10):605-9. PubMed ID: 7929532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
    Pasqualini JR; Gelly C; Nguyen BL
    Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.